USPTO serial 79304082
EVOTEC INDIGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2022
- Examiner
- BETTS, MARCYA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EVOTEC INDIGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William E OBrien, Esq.
William E OBrien, Esq. OBrien Global Law2 Connector Road, Suite 200Suite 200Westborough, MA 01581Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Pharmaceutical cost management services | ACTIVE | — |
| 042 | Medical and scientific research in the fields of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases; conducting clinical trials for others in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases,; clinical research in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases but also in many other indications in the fields of dermatology, haematology, ophthalmology, rare diseases; pharmaceutical research services; medical and scientific research consultation pertaining to pharmacology, toxicology, drug metabolism, pharmacokinetics, bioanalysis, and tablet compression; research of medicines; development of pharmaceutical preparations, formulations, drug substances, drug products, active pharmaceutical ingredients, and medicines; research to develop pharmaceutical products; design and testing of new pharmaceutical products for others | ACTIVE | — |
| 045 | Consultation in the field of regulatory compliance with respect to the pharmaceutical and medical products of others; regulatory compliance consulting services as they apply to clinical trials and preclinical drug development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Evotec International GmbH
- Other trademarks owned by Evotec International GmbH
- Other trademarks owned by Evotec International GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named EVOTEC INDIGO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 17, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 8, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 8, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 16, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 31, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 8, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 8, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |